The global Prostate Biopsy Devices Market is projected to experience a compound annual growth rate (CAGR) of 5.3% between 2022 and 2030, leading to substantial revenue growth. This growth can be attributed to several factors, with one of the primary drivers being the increasing prevalence of prostate cancer worldwide. In 2018 alone, the United States recorded nearly 161,360 new cases of prostate cancer, highlighting the urgent need for effective diagnostic tools such as biopsy devices.
Another significant factor contributing to the growth of the market is the rising global geriatric population, which is more susceptible to chronic diseases like prostate cancer. The United Nations defines individuals aged 60 and above as the elderly population, and according to the World Health Organization, this population segment is projected to reach 2 billion by 2050. Since prostate cancer is more commonly diagnosed in older men, with 65% of cases occurring in men aged 65 or above, the increasing elderly population is likely to drive the demand for prostate biopsy devices.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/5234
However, despite the promising growth prospects, the market for prostate biopsy devices faces certain challenges that may hinder its revenue growth. One such challenge is the implementation of stringent regulations for device approval. Meeting these regulatory requirements can be time-consuming and expensive for manufacturers, thus impeding the market's growth potential. Additionally, the easy availability of substitutes in the market is expected to limit revenue growth for prostate biopsy devices to some extent.
Key players in the Prostate Biopsy Devices Market:
· Cook Medical, Inc.
· C. R. Bard, Inc.
· B. Braun Melsungen AG
· Danaher Corporation (Hologic Inc.)
· Boston Scientific Corporation
· CONMED Corporation
· Teleflex Incorporated
These players actively engage in various strategies to drive revenue growth, such as product launches and approvals, mergers and acquisitions, geographical expansions, and partnerships, to maintain their competitive positions in the market.
The global market for prostate biopsy devices is segmented based on product type, guidance type, end-use, and region. In terms of product type, the market includes needles, kits & trays, and other related products. Needles accounted for a significant market share in 2021 and are expected to maintain their dominance throughout the forecast period. This can be attributed to the increasing number of needle-based prostate biopsy procedures being performed worldwide.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/5234
Guidance type is another crucial segment, which includes ultrasound-guided, MRI-guided, and other types of guidance. Among these, the ultrasound-guided segment is projected to achieve the highest revenue CAGR during the forecast period. This can be attributed to the growing preference for ultrasound-guided biopsy procedures over other alternatives. Factors such as the wide availability of ultrasound machines, ease of use, and lower cost associated with ultrasound-guided prostate biopsies contribute to its increasing popularity.
The market is further categorized based on end-use into hospitals & clinics and diagnostic centers. Hospitals & clinics are expected to account for a larger revenue share during the forecast period due to the increasing number of prostate biopsy procedures performed in these settings. However, diagnostic centers are projected to achieve the highest revenue CAGR during the forecast period, primarily driven by the increasing need for diagnostics to make appropriate treatment decisions.
Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held a significant revenue share in the global prostate biopsy devices market in 2021 and is expected to maintain its dominance throughout the forecast period. This can be attributed to factors such as the high prevalence of prostate cancer in the region and the availability of advanced healthcare infrastructure. Europe is expected to experience a significantly fast revenue growth rate during the forecast period, driven by increasing government initiatives to raise awareness for early diagnosis of prostate cancer and the presence of advanced healthcare infrastructure.
The Asia Pacific market is projected to achieve the highest revenue growth rate during the forecast period due to its large geriatric population base and the increasing prevalence of various chronic diseases, including prostate cancer.
For instance, in 2020, Cook Medical, Inc. received FDA clearance for its Zilver PTX Drug-Eluting Peripheral Stent System, which is used in the treatment of symptomatic peripheral artery disease. C. R. Bard, Inc. acquired Rochester Medical Corporation in 2019 to expand its product portfolio in the urology market. In the same year, B. Braun Melsungen AG launched the Xperius Stent System in Germany for the treatment of urethral stricture disease.
In conclusion, the global market for prostate biopsy devices is expected to witness substantial growth in the coming years, driven by factors such as the increasing prevalence of prostate cancer, the growing elderly population, and advancements in healthcare infrastructure. However, challenges related to regulatory approvals and the availability of substitutes may limit the market's revenue growth. By focusing on product innovation and strategic partnerships, key market players can capitalize on the opportunities presented by this expanding market.
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/5234
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports:
Acute Ischemia Monitors Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian